TJ 54

Drug Profile

TJ 54

Latest Information Update: 28 Jul 1999

Price : $50

At a glance

  • Originator Kansai Medical University; Tsumura
  • Developer Kansai Medical University
  • Class Antidementias; Herbal medicines; Neuroprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Dementia

Most Recent Events

  • 28 Jul 1999 No-Development-Reported for Dementia in Japan (PO)
  • 22 Jan 1997 Phase-II clinical trials for Dementia in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top